Financhill
Back

Phathom Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28

PHAT
Phathom Pharmaceuticals, Inc.

Last Price:
$11.16
Seasonality Move:
-6.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Phathom Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Phathom Pharmaceuticals, Inc. has on average historically fallen by 4.5% based on the past 6 years of stock performance.
  • Phathom Pharmaceuticals, Inc. has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Phathom Pharmaceuticals, Inc. Stock Undervalued?
    The current Phathom Pharmaceuticals, Inc. [PHAT] share price is $11.46. The Score for PHAT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Phathom Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Phathom Pharmaceuticals, Inc. has on average historically fallen by 4.5% based on the past 6 years of stock performance.

Phathom Pharmaceuticals, Inc. Stock Rating

Sell
28
Phathom Pharmaceuticals, Inc. (PHAT) is a Sell

Is Phathom Pharmaceuticals, Inc. overpriced?

  • Phathom Pharmaceuticals, Inc. has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Phathom Pharmaceuticals, Inc. Stock Price History

Is PHAT stock going to rise?

  • The current trend is moderately bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
phathompharma.com

52-Week Data

52-Week High:
18.31
52-Week Low:
2.21

Prediction Charts

Market Cap:
894M
Price in USD:
11.46
Volume:
2M
Beta:
0.81

Technical Analysis

SMA50:
14.29
SMA100:
14.10
SMA200:
11.71
52-Wk Change:
107.61%

Stock Predictions

  • Is Phathom Pharmaceuticals, Inc. stock public?
    Yes, Phathom Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Phathom Pharmaceuticals, Inc. stock quote today?
    The Phathom Pharmaceuticals, Inc. stock price is 11.46 USD today.
  • How to buy Phathom Pharmaceuticals, Inc. stock online?
    You can buy Phathom Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-10 13.00 12.82 13.07 12.74
Feb-11 12.80 12.23 13.17 12.19
Feb-12 12.38 12.02 12.41 11.83
Feb-13 12.20 12.02 12.50 11.95
Feb-17 12.03 12.76 12.83 11.83
Feb-18 12.61 11.88 13.05 11.86
Feb-19 11.72 11.98 11.99 11.38
Feb-20 11.90 11.42 12.05 11.22
Feb-23 11.42 11.37 11.71 11.00
Feb-24 11.30 11.61 11.69 11.19
Feb-25 11.63 12.32 12.65 11.42
Feb-26 13.00 13.56 14.39 12.95
Feb-27 13.53 12.56 13.76 12.32
Mar-2 12.12 11.46 12.33 11.44

Phathom Pharmaceuticals, Inc. Earnings

Phathom Pharmaceuticals, Inc. Earnings Report: Per Share Phathom Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Phathom Pharmaceuticals, Inc. Forecast Revenue Growth

Phathom Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Phathom Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.06 per share, an increase this year of $2.40 per share, and an increase next year of $1.54 per share.

* Phathom Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.